Skip to main content

Table 1 Results of the analyzed parameters in the allergy sub-groups and the control group

From: Clara cell protein in nasal lavage fluid and nasal nitric oxide - biomarkers with anti-inflammatory properties in allergic rhinitis

  Allergy sub-groups Control Group
  persistenta
(n = 13)
intermittentb
(n = 5)
groupc
(n = 7)
differences
Combined scores of: rhinitis symptoms 2.3 ± 2.8 0.7 ± 1.5 0.4 ± 1.1 a/c p = 0.06
bronchial symptoms 0.6 ± 1.3 0.0 0.0 n.s.
Levels of:     
CC16 (OD) 15 ± 9 18 ± 12 11 ± 9 n.s.
nNO (ppb) 70 ± 34 63 ± 30 79 ± 33 n.s.
eNO (ppb) 38 ± 41 13 ± 8 13 ± 5 a/b p = 0.06
a/c p = 0.05
Number of subjects:     
MCpos /MCneg 7/6 2/3 0/7 (a+b)/c p = 0.03
Eospos /Eosneg 9/4 2/3 2/4 n.s.
  1. Symptom scores, levels of CC16, nNO and eNO and the number of subjects with/without demonstrable metachromatic cells (MCpos/MCneg) and eosinophils (Eospos/Eosneg) in the allergy sub-groups and the control group. OD: optical density.